)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Echo IQ
Echo IQ (EIQ) investor relations material
Echo IQ Q1 2027 TU earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2027 TU earnings summary25 Oct, 2026
Executive summary
US commercial momentum strengthened, with EchoSolv AS full-result assessments up ~193% YoY in Q1 and ~406% for 9M CY26.
Priorities are converting US hospital engagement into contracted deployments and recurring revenue while progressing EchoSolv HF regulatory review and broader cardiovascular AI development.
A$110m institutional placement lifted cash to A$107.8m at 30 September 2026, supporting commercial expansion and product development.
Financial highlights
Net cash used in operating activities was A$5.876m for the quarter; investing outflows were A$0.551m.
Financing inflows were A$105.524m, comprising A$110m from the placement and A$1.298m from option exercises, less A$5.774m of transaction costs.
Cash and cash equivalents were A$107.784m at quarter end, versus A$8.712m at the start of the period.
Outlook and guidance
December-quarter priorities include converting the US pipeline into contracted enterprise deployments, growing EchoSolv AS utilisation and recurring assessment volumes, and progressing technical integrations.
Focus also includes advancing the EchoSolv HF regulatory pathway, clinical and health-economic evidence, reimbursement opportunities, Pro Medicus collaboration and Advara dataset implementation.
Management plans to build a scalable US business around FDA-cleared EchoSolv AS while pursuing additional cardiovascular indications.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Echo IQ
- FDA setback delays heart failure solution, but strong finances and US growth continue.EIQ
Investor update - Net loss widened to $18.6m as US expansion accelerated and capital was raised for future growth.EIQH2 2026
- AUD 110 million raised, FDA clearance imminent, and rapid commercial growth underway.EIQInvestor update
- Strategic partnerships and $110m funding drive rapid US expansion and AI adoption.EIQQ4 2026 TU
- Mayo Clinic and Mount Sinai deals drive U.S. expansion as FDA clearance and revenue ramp near.EIQInvestor update
- EchoSolv AS achieves rapid US adoption and pipeline growth, with solid cash reserves for expansion.EIQQ3 2026 TU
- Net loss increased to $8.66 million amid key clinical and regulatory milestones for US expansion.EIQH1 2026
- EchoSolv HF clinical validation and FDA submission mark pivotal US market progress; cash at $13.21m.EIQQ2 2026 TU
- AI platform validated at 99.5% sensitivity, FDA submission imminent, and rapid US market adoption expected.EIQStatus Update
Echo IQ
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)